4.1 Health History Review, ASA Physical Status & Medical Risk Assessment

Health History Review, ASA Physical Status & Medical Risk Assessment

Quick Answer: Dental hygienists must systematically evaluate patient health histories, vital signs, and ASA physical status classifications before initiating treatment. The ASA system categorizes patients from ASA I (healthy) through ASA IV (severe systemic disease presenting a constant life threat). Updated AHA guidelines limit antibiotic prophylaxis to high-risk cardiac conditions (prosthetic valves, prior IE, uncorrected cyanotic CHD), prescribing Amoxicillin 2g (or Cephalexin 2g, Azithromycin 500mg, Doxycycline 100mg for penicillin allergy; Clindamycin is no longer recommended). Stage 2 hypertension requires cautious epinephrine administration (max 0.04 mg), and bisphosphonate history necessitates screening for Medication-Related Osteonecrosis of the Jaw (MRONJ).

1. Systematic Health History Intake and Interview

The dental hygiene process of care begins with a comprehensive, evidence-based health history review. This critical assessment forms the legal and clinical foundation for all subsequent care planning, risk stratification, and safe treatment delivery. Obtaining a medical history is not merely a passive record-keeping exercise; it requires an active, structured clinical interview to elicit accurate self-reported data and identify hidden systemic vulnerabilities.

Core Components of the Patient History:

• Chief Complaint (CC): The primary reason for the patient's visit, recorded in the patient's own words (e.g., "My gums bleed when I brush").
• History of Present Illness (HPI): Detailed timeline and characterization of the chief complaint, including onset, duration, location, severity, and aggravating/relieving factors.
• Past Medical History (PMH): Systematic review of systemic conditions, surgeries, hospitalizations, allergies, and organ system function.
• Pharmacological History: Comprehensive inventory of all prescription medications, over-the-counter (OTC) drugs, botanical supplements, and recreational substances. Every medication must be cross-referenced for oral side effects (e.g., xerostomia, gingival enlargement, lichenoid reactions) and potential drug interactions with dental agents (e.g., local anesthetics, vasoconstrictors).
• Past Dental History (PDH): Previous dental procedures, frequency of care, dental anxieties, past complications with local anesthesia, and oral hygiene habits.
• Review of Systems (ROS): A targeted, head-to-toe questionnaire evaluating cardiorespiratory, endocrine, hematologic, renal, hepatic, and neurological health.

Vital Signs Screening and Baseline Benchmarks:

Vital signs must be measured and recorded at initial visits and updated at every recare appointment. Baseline vitals provide essential clues regarding underlying systemic illness and serve as a reference during medical emergencies.

Blood Pressure Classification (AHA/ACC Standards):

• Normal: Systolic <120 mmHg AND Diastolic <80 mmHg.
• Elevated: Systolic 120-129 mmHg AND Diastolic <80 mmHg. Re-evaluate lifestyle factors.
• Stage 1 Hypertension: Systolic 130-139 mmHg OR Diastolic 80-89 mmHg. Recommend medical consult; proceed with routine dental hygiene care.
• Stage 2 Hypertension: Systolic >=140 mmHg OR Diastolic >=90 mmHg. Recheck BP after 5 minutes. Obtain medical consultation. Limit epinephrine to a cardiac dose (0.04 mg per appointment, equivalent to 2 cartridges of 1:100,000 epinephrine).
• Hypertensive Crisis: Systolic >180 mmHg and/or Diastolic >120 mmHg. Recheck immediately. If patient is asymptomatic, contact physician immediately for emergency evaluation. If symptomatic (chest pain, shortness of breath, severe headache), activate Emergency Medical Services (EMS) immediately. All elective dental procedures are strictly contraindicated.

---

2. ASA Physical Status Classification System

The American Society of Anesthesiologists (ASA) Physical Status Classification System is the universally accepted framework for assessing patient medical risk prior to surgical and dental procedures. Hygienists use the ASA score to modify care plans, select local anesthetics, and determine stress reduction requirements.

ASA Physical Status Spectrum:
[ASA I: Healthy] ---> [ASA II: Mild Disease] ---> [ASA III: Severe Disease] ---> [ASA IV: Threat to Life]

ASA Classification Categories and Dental Considerations:

• ASA I: Normal, Healthy Patient

  • Characteristics: No systemic disease; non-smoker; minimal alcohol use; good exercise tolerance (able to walk up a flight of stairs or two city blocks without shortness of breath or chest pain).
  • Dental Management: Standard dental hygiene care without special modifications.

• ASA II: Patient with Mild Systemic Disease

  • Characteristics: Systemic disease without significant functional limitations. Examples include controlled Stage 1 hypertension, controlled type 2 diabetes mellitus (HbA1c < 7.0%), well-controlled asthma, mild obesity (BMI 30-39), cigarette smoking without COPD, active pregnancy, or age > 65.
  • Dental Management: Minimal treatment modifications; consider stress reduction protocol, morning appointments, and monitoring pre-treatment vitals.

• ASA III: Patient with Severe Systemic Disease with Functional Limitation

  • Characteristics: Severe systemic disease that limits activity but is not incapacitating. Examples include poorly controlled hypertension (Stage 2: >=140/>=90 mmHg), poorly controlled diabetes (HbA1c >= 8.0%), stable angina pectoris, history of myocardial infarction (MI) or cerebrovascular accident (CVA) > 6 months ago, controlled insulin-dependent type 1 diabetes, COPD, morbid obesity (BMI >= 40), end-stage renal disease (ESRD) on regular hemodialysis, or symptomatic thyroid dysfunction.
  • Dental Management: Formal medical consultation recommended; strict vasoconstrictor limits (max 0.04 mg epinephrine); keep appointments short; monitor intraoperative vitals; employ nitrous oxide-oxygen conscious sedation if indicated.

• ASA IV: Patient with Severe Systemic Disease that is a Constant Threat to Life

  • Characteristics: Incapacitating systemic disease presenting an ongoing life threat. Examples include unstable angina pectoris, recent myocardial infarction (MI) or stroke (CVA) within the past 6 months, severe heart failure (NYHA Class IV), uncontrolled epilepsy with frequent seizures, severe liver failure, or end-stage renal disease not receiving dialysis.
  • Dental Management: Elective dental hygiene care is strictly contraindicated. Emergency palliative treatment (e.g., pain relief, infection control) should be provided in a hospital or specialized clinical setting in consultation with the patient's physician.

• ASA V and ASA VI: ASA V represents a moribund patient not expected to survive 24 hours without an operation (e.g., ruptured abdominal aneurysm). ASA VI represents a declared brain-dead patient whose organs are being harvested for donor purposes.

---

3. Antibiotic Prophylaxis Guidelines (AHA Standards)

Infective endocarditis (IE) is a rare but life-threatening microbial infection of the endocardial surface or heart valves. Transient bacteremia induced by invasive dental hygiene procedures (e.g., subgingival scaling, root planing, periodontal probing, matrix band placement) can seed damaged heart tissue. Current American Heart Association (AHA) guidelines restrict antibiotic prophylaxis strictly to patients at the highest risk of adverse outcomes from infective endocarditis.

Cardiac Conditions Requiring Antibiotic Prophylaxis:

1. Prosthetic cardiac valves or prosthetic material used for cardiac valve repair.
2. Previous history of infective endocarditis.
3. Congenital Heart Disease (CHD):
   • Uncorrected cyanotic CHD, including palliative shunts and conduits.
   • Completely repaired congenital heart defect with prosthetic material or device, during the first 6 months after the procedure.
   • Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device.
4. Cardiac transplant recipients who develop cardiac valvulopathy.

Cardiac Conditions NO LONGER Requiring Prophylaxis:

Antibiotic prophylaxis is NOT recommended for mitral valve prolapse (MVP) with or without regurgitation, rheumatic heart disease, bicuspid aortic valve, calcific aortic stenosis, ventricular septal defect (VSD), atrial septal defect (ASD), coronary artery bypass graft (CABG) surgery, cardiac pacemakers, or prosthetic joint replacements (unless specifically mandated by the orthopedic surgeon for high-risk immunocompromised individuals).

Standard AHA Antibiotic Regimens (Administered 30 to 60 Minutes Before Procedure):

** Note on Cephalexin: Cephalosporins should NOT be used in patients with a history of immediate hypersensitivity (anaphylaxis, angioedema, or urticaria) to penicillins.*

CRITICAL EXAM ALERT: Clindamycin is NO LONGER recommended by the AHA for infective endocarditis antibiotic prophylaxis due to documented risks of severe, potentially fatal Clostridioides difficile colitis!

---

4. Special Medical Risk Management Protocols

Anticoagulated Patients (Warfarin vs. DOACs):

• Warfarin (Coumadin): Inhibits vitamin K-dependent clotting factors (II, VII, IX, X). Requires monitoring of the International Normalized Ratio (INR). Safe dental hygiene treatment (scaling/debridement) can proceed if the INR is between 2.0 and 3.0 (up to 3.5 for minor non-surgical procedures). High INR (>3.5) increases hemorrhage risk and requires medical consultation. NEVER instruct a patient to stop warfarin without direct physician orders.
• Direct Oral Anticoagulants (DOACs): Include apixaban (Eliquis), rivaroxaban (Xarelto), and dabigatran (Pradaxa). DOACs do not require routine INR monitoring. Dental hygiene procedures can usually be performed safely at trough drug levels (just prior to the next scheduled dose).

Bisphosphonates and MRONJ Risk:

• Medication-Related Osteonecrosis of the Jaw (MRONJ): Characterized by exposed necrotic bone in the maxillofacial region persisting for >8 weeks in patients with current or prior antiresorptive (bisphosphonate, denosumab) therapy and no history of radiation therapy to the jaws.
• High Risk: Intravenous bisphosphonates (e.g., zoledronic acid, pamidronate) used in cancer chemotherapy.
• Lower Risk: Oral bisphosphonates (e.g., alendronate/Fosamax) used for osteoporosis.
• Hygiene Management: Emphasize non-surgical periodontal maintenance, maintain immaculate oral hygiene, minimize soft tissue trauma, and avoid extractions or invasive osseous procedures.

Angina Pectoris Emergency Protocol:

If a patient experiences chest pain during dental hygiene treatment:

1. Terminate dental procedure immediately and position patient comfortably (usually upright).
2. Administer patient's own sublingual Nitroglycerin (0.4 mg tablet or spray) under the tongue. Repeat every 5 minutes up to a maximum of 3 doses over 15 minutes.
3. Administer 100% oxygen via nasal cannula or mask.
4. Monitor blood pressure and pulse.
5. If pain is not relieved after 2 doses, or if accompanied by diaphoresis, nausea, or shortness of breath, activate EMS (call 911) immediately for suspected Myocardial Infarction.